Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Net Margin: 2009-2024

Historic Net Margin for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to 41.53%.

  • UNITED THERAPEUTICS's Net Margin rose 109.00% to 42.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 53.33%, marking a year-over-year increase of 1302.00%. This contributed to the annual value of 41.53% for FY2024, which is 78.00% down from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Net Margin stood at 41.53% for FY2024, which was down 1.84% from 42.31% recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Net Margin registered a high of 42.31% during FY2023, and its lowest value of 28.23% during FY2021.
  • Moreover, its 3-year median value for Net Margin was 41.53% (2024), whereas its average is 40.47%.
  • Its Net Margin has fluctuated over the past 5 years, first soared by 4,192bps in 2020, then tumbled by 648bps in 2021.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's Net Margin stood at 34.71% in 2020, then plummeted by 648bps to 28.23% in 2021, then surged by 933bps to 37.56% in 2022, then skyrocketed by 475bps to 42.31% in 2023, then crashed by 78bps to 41.53% in 2024.